Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.

By V. Schächinger, B. Assmus, M. Britten, Jörg Honold, R. Lehmann, C. Teupe, N. Abolmaali, T. Vogl, W. Hofmann, H. Martin and 2 more. Journal of the American College of Cardiology, 2004

1,091 citations recorded by the source corpus.

Subfields: Genetics, Molecular Biology, Surgery

View Paper: https://www.semanticscholar.org/paper/7c33756bb174674979c69354066eb37cb0e3f233

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Stefanie Dimmeler
2. A. Zeiher
3. M. Schneider

Citations in the corpus

• Unchain my heart: the scientific foundations of cardiac repair. (2005, background): “9 CPCs 250 ml/blood/3 days 16 + Global contractility ↑ (LVA/MRI); (13, 17, 122) end systolic volume ↓ (LVA/MRI); viability ↑ (MRI); BMCs 50 ml/Ficoll/none 213 flow reserve ↑ (Doppler); similar results for both cell types”
• Intracoronary Bone Marrow Cell Transfer After Myocardial Infarction: Eighteen Months’ Follow-Up Data From the Randomized, Controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) Trial (2006, neutral): “Heart failure hospitalization 3 (10) 1 (3)”